Biodegradable-polymer-based, paclitaxel eluting infinnium, stent, 9-month clinical, angiographic follow-up, results from the SIMPLE II, prospective, multi-centre, registry study,
Home About Us Products Clinical Trials Media Career Contact Us
      HOME
Quick Search:
 
Latest News
May 13th, 2008-Sahajanand Medical Technologies Pvt. Ltd. (SMT), leading developer and manufacturer of drug-eluting stents, welcomed today the positive results of the prospective, randomized nine months results of PAINT trial (PercutAneous INTervention with biodegradable-polymer based Paclitaxel-eluting, Sirolimus-eluting, or bare stents for the treatment     Read More...
 
 Products Overview
Infinnium-Core™ Paclitaxel Eluting Coronary Stent System has a biodegradable... Learn More...  
Supralimus-Core™ Sirolimus Eluting Coronary Stent System is based on the three powerful... Learn More...  
The Supralimus® is based on the three powerful tools. The CE approved The Millennium Matrix® Stent... Learn More...  
The Coronnium® (CE approved) Cobalt Chromium Coronary Stent System contains... Learn More...  
The Infinnium® (CE approved) Paclitaxel Eluting Coronary Stent System contains Biodegradable... Learn More...  
The Millennium Matrix® (CE approved) Coronary Stent System contains excellent technical features like... Learn More...  
Sahajanand Medical Technologies Pvt. Ltd. - "Sahajanand Estate", Wakhariawadi, Nr. Dabholi Char Rasta, Ved Road, Surat - 395004 (Guj.), India
Tel: +91-261-2521251-58 Fax: +91-261-2520252 © Copyright 2008. All rights reserved. Last Update: 2008/05/14